"Rabies Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis.
Descriptor ID |
D011819
|
MeSH Number(s) |
D20.215.894.899.700
|
Concept/Terms |
Rabies Vaccines- Rabies Vaccines
- Vaccines, Rabies
- Rabies Vaccine
- Vaccine, Rabies
|
Below are MeSH descriptors whose meaning is more general than "Rabies Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Rabies Vaccines".
This graph shows the total number of publications written about "Rabies Vaccines" by people in this website by year, and whether "Rabies Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 2 | 0 | 2 |
2003 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2005 | 3 | 0 | 3 |
2006 | 4 | 1 | 5 |
2007 | 2 | 0 | 2 |
2008 | 1 | 0 | 1 |
2009 | 2 | 0 | 2 |
2010 | 2 | 1 | 3 |
2011 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2015 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rabies Vaccines" by people in Profiles.
-
Ben Hamed S, Myers JF, Chandwani A, Wirblich C, Kurup D, Paran N, Schnell MJ. Toward the Development of a Pan-Lyssavirus Vaccine. Viruses. 2024 Jul 10; 16(7).
-
Kurup D, Wirblich C, Zabihi Diba L, Lambert R, Watson M, Shaikh N, Ramage H, Solomides C, Schnell MJ. A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model. Viruses. 2022 May 24; 14(6).
-
Haley SL, Tzvetkov EP, Meuwissen S, Plummer JR, McGettigan JP. Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis. J Virol. 2017 Apr 15; 91(8).
-
Gnanadurai CW, Yang Y, Huang Y, Li Z, Leyson CM, Cooper TL, Platt SR, Harvey SB, Hooper DC, Faber M, Fu ZF. Differential Host Immune Responses after Infection with Wild-Type or Lab-Attenuated Rabies Viruses in Dogs. PLoS Negl Trop Dis. 2015; 9(8):e0004023.
-
Li J, Ertel A, Portocarrero C, Barkhouse DA, Dietzschold B, Hooper DC, Faber M. Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues. J Virol. 2012 Mar; 86(6):3200-10.
-
Blaney JE, Wirblich C, Papaneri AB, Johnson RF, Myers CJ, Juelich TL, Holbrook MR, Freiberg AN, Bernbaum JG, Jahrling PB, Paragas J, Schnell MJ. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses. J Virol. 2011 Oct; 85(20):10605-16.
-
McGettigan JP. Experimental rabies vaccines for humans. Expert Rev Vaccines. 2010 Oct; 9(10):1177-86.
-
Wanjalla CN, Faul EJ, Gomme EA, Schnell MJ. Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity. Vaccine. 2010 Dec 10; 29(1):130-40.
-
Gomme EA, Faul EJ, Flomenberg P, McGettigan JP, Schnell MJ. Characterization of a single-cycle rabies virus-based vaccine vector. J Virol. 2010 Mar; 84(6):2820-31.
-
Cenna J, Hunter M, Tan GS, Papaneri AB, Ribka EP, Schnell MJ, Marx PA, McGettigan JP. Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates. J Infect Dis. 2009 Oct 15; 200(8):1251-60.